{"title":"放射与免疫疗法的结合——目前的科学研究","authors":"A. Deja","doi":"10.21641/los.15.3.86","DOIUrl":null,"url":null,"abstract":"In recent years, it has been noted that the combination of radiation and immunotherapy is more benefitial than both modalities used separately. The interactions between immune checkpoint inhibitors and high-dose radiotherapy are curently an important topic of ongoing scientific trials. This review highlights some of the presented papers during the ESTRO 37 congress in 2018.","PeriodicalId":18098,"journal":{"name":"Letters in Oncology Science","volume":"18 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2018-09-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Combination of radiation and immunotherapy – current scientific research\",\"authors\":\"A. Deja\",\"doi\":\"10.21641/los.15.3.86\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"In recent years, it has been noted that the combination of radiation and immunotherapy is more benefitial than both modalities used separately. The interactions between immune checkpoint inhibitors and high-dose radiotherapy are curently an important topic of ongoing scientific trials. This review highlights some of the presented papers during the ESTRO 37 congress in 2018.\",\"PeriodicalId\":18098,\"journal\":{\"name\":\"Letters in Oncology Science\",\"volume\":\"18 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2018-09-11\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Letters in Oncology Science\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.21641/los.15.3.86\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Letters in Oncology Science","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.21641/los.15.3.86","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Combination of radiation and immunotherapy – current scientific research
In recent years, it has been noted that the combination of radiation and immunotherapy is more benefitial than both modalities used separately. The interactions between immune checkpoint inhibitors and high-dose radiotherapy are curently an important topic of ongoing scientific trials. This review highlights some of the presented papers during the ESTRO 37 congress in 2018.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
